Literature DB >> 27194467

Prognostic Significance of Insomnia in Heart Failure.

Yuki Kanno1, Akiomi Yoshihisa, Shunsuke Watanabe, Mai Takiguchi, Tetsuro Yokokawa, Akihiko Sato, Shunsuke Miura, Takeshi Shimizu, Yuichi Nakamura, Satoshi Abe, Takamasa Sato, Satoshi Suzuki, Masayoshi Oikawa, Shu-Ichi Saitoh, Yasuchika Takeishi.   

Abstract

BACKGROUND: Insomnia is associated with incident heart failure (HF), but the clinical significance and impact of insomnia on HF remain unclear. METHODS AND 
RESULTS: Consecutive 1,011 patients admitted for HF were divided into 2 groups according to the presence of insomnia: HF with insomnia (insomnia group, n=519) and HF without insomnia (non-insomnia group, n=492). We compared (1) cardiac event rates including cardiac death and worsening HF; and (2) underlying clinical background including laboratory data, echocardiographic data, and cardiopulmonary exercise test between the 2 groups. On Kaplan-Meier analysis, cardiac event rate was significantly higher in the insomnia group than in the non-insomnia group (39.1 vs. 23.4%, P<0.001). The insomnia group, as compared with the non-insomnia group, had (1) higher plasma renin activity (P=0.042), renin concentration (P=0.007), and aldosterone (P=0.047); (2) lower peak V̇O2(14.9 vs. 16.3 ml/kg/min, P=0.002) and higher V̇E/V̇CO2slope (36.0 vs. 33.5, P=0.001); and (3) similar B-type natriuretic peptide and left ventricular ejection fraction. Importantly, on multivariate Cox proportional hazard analysis after adjusting for potential confounding factors, insomnia was an independent predictor of cardiac events in HF patients (hazard ratio, 1.899; P<0.001).
CONCLUSIONS: Insomnia is an independent predictor of cardiac events in HF patients. HF patients with insomnia have activated renin-angiotensin-aldosterone system and lower exercise capacity. (Circ J 2016; 80: 1571-1577).

Entities:  

Mesh:

Year:  2016        PMID: 27194467     DOI: 10.1253/circj.CJ-16-0205

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  17 in total

1.  Effects of Cognitive Behavioral Therapy for Insomnia on Sleep, Symptoms, Stress, and Autonomic Function Among Patients With Heart Failure.

Authors:  Nancy S Redeker; Samantha Conley; George Anderson; John Cline; Laura Andrews; Vahid Mohsenin; Daniel Jacoby; Sangchoon Jeon
Journal:  Behav Sleep Med       Date:  2018-11-21       Impact factor: 2.964

2.  Effects of Cognitive Behavioral Therapy for Insomnia on Sleep-Related Cognitions Among Patients With Stable Heart Failure.

Authors:  Nancy S Redeker; Sangchoon Jeon; Laura Andrews; John Cline; Vahid Mohsenin; Daniel Jacoby
Journal:  Behav Sleep Med       Date:  2017-08-22       Impact factor: 2.964

3.  Sex differences in sleep and psychological disturbances among patients admitted for cardiovascular diseases.

Authors:  Yuichi Jono; Takashi Kohno; Shun Kohsaka; Hiroki Kitakata; Yasuyuki Shiraishi; Yoshinori Katsumata; Kentaro Hayashida; Shinsuke Yuasa; Seiji Takatsuki; Keiichi Fukuda
Journal:  Sleep Breath       Date:  2022-01-06       Impact factor: 2.816

4.  Benzodiazepines in Patients with Heart Failure and Reduced Ejection Fraction.

Authors:  Chi Chuang; Fu-Chih Hsiao; Yu-Wen Cheng; Chia-Pin Lin; Ying-Chang Tung; Chia-Tung Wu; Ching-Yen Chen; Pao-Hsien Chu
Journal:  Acta Cardiol Sin       Date:  2022-09       Impact factor: 1.800

5.  Cognitive behavioral therapy for insomnia has sustained effects on insomnia, fatigue, and function among people with chronic heart failure and insomnia: the HeartSleep Study.

Authors:  Nancy S Redeker; Henry Klar Yaggi; Daniel Jacoby; Christopher S Hollenbeak; Stephen Breazeale; Samantha Conley; Youri Hwang; Joanne Iennaco; Sarah Linsky; Uzoji Nwanaji-Enwerem; Meghan O'Connell; Sangchoon Jeon
Journal:  Sleep       Date:  2022-01-11       Impact factor: 6.313

6.  Comorbid Insomnia With Obstructive Sleep Apnea: Clinical Characteristics and Risk Factors.

Authors:  Yong Won Cho; Keun Tae Kim; Hye-Jin Moon; Valeriy R Korostyshevskiy; Gholam K Motamedi; Kwang Ik Yang
Journal:  J Clin Sleep Med       Date:  2018-03-15       Impact factor: 4.062

7.  Serum TRACP5b, a Marker of Bone Resorption, Is Associated With Adverse Cardiac Prognosis in Hospitalized Patients With Heart Failure.

Authors:  Satoshi Abe; Akiomi Yoshihisa; Yasuhiro Ichijo; Yusuke Kimishima; Tetsuro Yokokawa; Tomofumi Misaka; Takamasa Sato; Masayoshi Oikawa; Atsushi Kobayashi; Takashi Kaneshiro; Kazuhiko Nakazato; Yasuchika Takeishi
Journal:  CJC Open       Date:  2020-12-13

8.  Perceived Stress, Subjective, and Objective Symptoms of Disturbed Sleep in Men and Women with Stable Heart Failure.

Authors:  Allison E Gaffey; Sangchoon Jeon; Samantha Conley; Daniel Jacoby; Garrett I Ash; Henry K Yaggi; Meghan O'Connell; Sarah J Linsky; Nancy S Redeker
Journal:  Behav Sleep Med       Date:  2020-05-12       Impact factor: 2.964

9.  Associations of Benzodiazepine With Adverse Prognosis in Heart Failure Patients With Insomnia.

Authors:  Yu Sato; Akiomi Yoshihisa; Yu Hotsuki; Koichiro Watanabe; Yusuke Kimishima; Takatoyo Kiko; Yuki Kanno; Tetsuro Yokokawa; Satoshi Abe; Tomofumi Misaka; Takamasa Sato; Masayoshi Oikawa; Atsushi Kobayashi; Takayoshi Yamaki; Hiroyuki Kunii; Kazuhiko Nakazato; Takafumi Ishida; Yasuchika Takeishi
Journal:  J Am Heart Assoc       Date:  2020-03-21       Impact factor: 5.501

10.  Bypassing the blues: Insomnia in the depressed post-CABG population.

Authors:  Lauren A Waterman; Bea Herbeck Belnap; Marie Anne Gebara; Yan Huang; Kaleab Z Abebe; Bruce L Rollman; Jordan F Karp
Journal:  Ann Clin Psychiatry       Date:  2020-02       Impact factor: 1.567

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.